115 related articles for article (PubMed ID: 28287050)
41. Effect of tolterodine on the anticoagulant actions and pharmacokinetics of single-dose warfarin in healthy volunteers.
Rahimy M; Hallén B; Narang P
Arzneimittelforschung; 2002; 52(12):890-5. PubMed ID: 12572529
[TBL] [Abstract][Full Text] [Related]
42. Lack of effect of multiple doses of vortioxetine on the pharmacokinetics and pharmacodynamics of aspirin and warfarin.
Chen G; Zhang W; Serenko M
J Clin Pharmacol; 2015 Jun; 55(6):671-9. PubMed ID: 25641606
[TBL] [Abstract][Full Text] [Related]
43. The effect of CYP2C19 genotypes on the pharmacokinetics of warfarin enantiomers.
Uno T; Sugimoto K; Sugawara K; Tateishi T
J Clin Pharm Ther; 2008 Feb; 33(1):67-73. PubMed ID: 18211619
[TBL] [Abstract][Full Text] [Related]
44. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Van Hecken A; Depré M; Verbesselt R; Wynants K; De Lepeleire I; Arnout J; Wong PH; Freeman A; Holland S; Gertz B; De Schepper PJ
J Clin Pharmacol; 1999 May; 39(5):495-500. PubMed ID: 10234597
[TBL] [Abstract][Full Text] [Related]
45. Anlotinib and fruquintinib co-administrated with warfarin increases the risk of bleeding: Studied from pharmacokinetic and pharmacodynamic perspectives.
Fang B; Jin S; Du W; Cai W
Eur J Pharm Sci; 2023 Sep; 188():106507. PubMed ID: 37364727
[TBL] [Abstract][Full Text] [Related]
46. Effects of cucurbitacin e, a tetracyclic triterpene compound from Cucurbitaceae, on the pharmacokinetics and pharmacodynamics of warfarin in rats.
Ding T; Zhang Y; Chen A; Tang Y; Liu M; Wang X
Basic Clin Pharmacol Toxicol; 2015 May; 116(5):385-9. PubMed ID: 25250504
[TBL] [Abstract][Full Text] [Related]
47. Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects.
Lilja JJ; Backman JT; Neuvonen PJ
Br J Clin Pharmacol; 2005 Apr; 59(4):433-9. PubMed ID: 15801938
[TBL] [Abstract][Full Text] [Related]
48. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
[TBL] [Abstract][Full Text] [Related]
49. Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer.
Hata T; Kudo T; Sakai D; Takahashi H; Haraguchi N; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M; Satoh T
Cancer Chemother Pharmacol; 2016 Aug; 78(2):389-96. PubMed ID: 27339150
[TBL] [Abstract][Full Text] [Related]
50. Influence of andrographolide on the pharmacokinetics of warfarin in rats.
Zhang X; Zhang X; Wang X; Zhao M
Pharm Biol; 2018 Dec; 56(1):351-356. PubMed ID: 29983086
[TBL] [Abstract][Full Text] [Related]
51. Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteers.
Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1331-7. PubMed ID: 11185631
[TBL] [Abstract][Full Text] [Related]
52. Potentiation of the anticoagulation effect of warfarin by the herbal remedy Shu-Jing-Hwo-Shiee-Tang in rats: The dosing regimen and pharmacokinetic interaction.
Ueng YF; Lu CK; Yang SH; Wang HJ; Huang CC
Drug Metab Pharmacokinet; 2017 Feb; 32(1):85-91. PubMed ID: 28111103
[TBL] [Abstract][Full Text] [Related]
53. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
Sun H; Zhang T; Wu Z; Wu B
J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
[TBL] [Abstract][Full Text] [Related]
54. Curcumin alters the pharmacokinetics of warfarin and clopidogrel in Wistar rats but has no effect on anticoagulation or antiplatelet aggregation.
Liu AC; Zhao LX; Lou HX
Planta Med; 2013 Jul; 79(11):971-7. PubMed ID: 23807811
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin.
Zhou L; Wang S; Zhang Z; Lau BS; Fung KP; Leung PC; Zuo Z
J Ethnopharmacol; 2012 Sep; 143(2):648-55. PubMed ID: 22867637
[TBL] [Abstract][Full Text] [Related]
56. The effect of Compound Danshen Dripping Pills, a Chinese herb medicine, on the pharmacokinetics and pharmacodynamics of warfarin in rats.
Chu Y; Zhang L; Wang XY; Guo JH; Guo ZX; Ma XH
J Ethnopharmacol; 2011 Oct; 137(3):1457-61. PubMed ID: 21878380
[TBL] [Abstract][Full Text] [Related]
57. The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
Schwartz JI; Bugianesi KJ; Ebel DL; De Smet M; Haesen R; Larson PJ; Ko A; Verbesselt R; Hunt TL; Lins R; Lens S; Porras AG; Dieck J; Keymeulen B; Gertz BJ
Clin Pharmacol Ther; 2000 Dec; 68(6):626-36. PubMed ID: 11180023
[TBL] [Abstract][Full Text] [Related]
58. Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin.
Depré M; Van Hecken A; Oeyen M; De Lepeleire I; Laethem T; Rothenberg P; Petty KJ; Majumdar A; Crumley T; Panebianco D; Bergman A; de Hoon JN
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):341-6. PubMed ID: 15983826
[TBL] [Abstract][Full Text] [Related]
59. Effect of ubidecarenone on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
Zhou S; Chan E
Drug Metabol Drug Interact; 2001; 18(2):99-122. PubMed ID: 11460879
[TBL] [Abstract][Full Text] [Related]
60. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
